DK0604657T3 - Phosphonsyrediesterderivat - Google Patents

Phosphonsyrediesterderivat

Info

Publication number
DK0604657T3
DK0604657T3 DK93910361T DK93910361T DK0604657T3 DK 0604657 T3 DK0604657 T3 DK 0604657T3 DK 93910361 T DK93910361 T DK 93910361T DK 93910361 T DK93910361 T DK 93910361T DK 0604657 T3 DK0604657 T3 DK 0604657T3
Authority
DK
Denmark
Prior art keywords
phosphonic acid
acid diester
diester derivatives
derivatives
hyperlipidemia
Prior art date
Application number
DK93910361T
Other languages
English (en)
Inventor
Kazuyoshi Miyata
Yasuo Shoji
Yoshihiko Tsuda
Kazuhiko Tsutsumi
Yasuhide Inoue
Chieko Naba
Yasuhisa Kurogi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK0604657T3 publication Critical patent/DK0604657T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93910361T 1992-05-21 1993-05-20 Phosphonsyrediesterderivat DK0604657T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12871192 1992-05-21
PCT/JP1993/000660 WO1993023409A1 (fr) 1992-05-21 1993-05-20 Derive de diester phosphonique

Publications (1)

Publication Number Publication Date
DK0604657T3 true DK0604657T3 (da) 2000-04-17

Family

ID=14991544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93910361T DK0604657T3 (da) 1992-05-21 1993-05-20 Phosphonsyrediesterderivat

Country Status (13)

Country Link
US (1) US5376665A (da)
EP (1) EP0604657B1 (da)
JP (1) JP2759228B2 (da)
KR (1) KR0185225B1 (da)
AT (1) ATE188704T1 (da)
AU (1) AU653681B2 (da)
CA (1) CA2113561C (da)
DE (1) DE69327572T2 (da)
DK (1) DK0604657T3 (da)
ES (1) ES2140456T3 (da)
PT (1) PT604657E (da)
TW (1) TW243451B (da)
WO (1) WO1993023409A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW260664B (da) * 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
JP3156026B2 (ja) 1993-12-27 2001-04-16 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
JP3533542B2 (ja) * 1994-03-08 2004-05-31 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US5442118A (en) * 1994-04-22 1995-08-15 Sepracor, Inc. Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones
US6288100B1 (en) 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
DE69624143T2 (de) * 1995-12-27 2003-06-12 Otsuka Pharmaceutical Factory, Inc. Phosphonsaurediester-derivate
CA2259487A1 (en) 1996-07-01 1998-01-08 Margaret Mary Faul Hypoglycemic and hypolipidemic compounds
CA2259431A1 (en) * 1996-07-01 1998-01-08 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
DE69819311T2 (de) * 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
WO1998039344A1 (en) * 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
EP1402895A1 (en) * 1997-03-07 2004-03-31 Metabasis Therapeutics, Inc. Benzimidazole inhibitors of fructose 1,6-biphosphatase
JP2002507996A (ja) 1997-07-03 2002-03-12 デュポン ファーマシューティカルズ カンパニー 神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
RU2251419C2 (ru) 2000-06-21 2005-05-10 Ф. Хоффманн-Ля Рош Аг Производные бензотиазола
US20040029867A1 (en) * 2001-05-04 2004-02-12 Scarborough Robert M. Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
EP1434579B1 (en) 2001-10-09 2011-06-08 Amgen Inc. Imidazole derivatives as antiinflammatory agents
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
BRPI0411699A (pt) 2003-06-20 2006-08-29 Hoffmannn La Roche Ag F compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
US20050130974A1 (en) * 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
AU2005247567B2 (en) 2004-05-24 2010-09-02 F. Hoffmann-La Roche Ag 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
EP1812392B1 (en) 2004-11-05 2008-07-09 F.Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
PT1863818E (pt) 2005-03-23 2010-04-09 Hoffmann La Roche Derivados de acetilenil-pirazolo-pirimidina como antagonistas de mglur2
ATE463495T1 (de) 2005-09-27 2010-04-15 Hoffmann La Roche Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) * 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
US8410284B2 (en) * 2008-10-22 2013-04-02 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
SG10201505997TA (en) 2010-08-05 2015-09-29 Amgen Inc Benzimidazole And Azabenzimidazole Compounds That Inhibit Anaplastic Lymphoma Kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0604657A4 (en) 1995-03-15
KR0185225B1 (ko) 1999-05-15
ATE188704T1 (de) 2000-01-15
WO1993023409A1 (fr) 1993-11-25
AU4088793A (en) 1993-12-13
US5376665A (en) 1994-12-27
EP0604657B1 (en) 2000-01-12
PT604657E (pt) 2000-04-28
CA2113561A1 (en) 1993-11-25
DE69327572D1 (de) 2000-02-17
JP2759228B2 (ja) 1998-05-28
CA2113561C (en) 1999-09-14
ES2140456T3 (es) 2000-03-01
EP0604657A1 (en) 1994-07-06
DE69327572T2 (de) 2000-06-21
TW243451B (da) 1995-03-21
AU653681B2 (en) 1994-10-06

Similar Documents

Publication Publication Date Title
DE69327572D1 (de) Phosphonsäurediester-derivat
NO976085D0 (no) Difenylmetylen-piperidin-derivater
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
FI92695B (fi) Uusi menetelmä heksa-, okta- tai dekahydronaftyylietyylisubstituoitujen 4-hydroksitetrahydropyran-2-onijohdannaisten valmistamiseksi
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
NO894299D0 (no) Fremgangsmaate for fremstilling av pyrimidindion-derivater.
CA2015473A1 (en) Triphenylmethane derivatives
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
ATE205469T1 (de) Phenylbenzoesäureester-derivate und flüssigkristallzubereitungen
ATE155127T1 (de) Benzamid-derivate
FI893682A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
GR3007465T3 (da)
SE8704542D0 (sv) New derivatives of cysteine
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet
ATE146481T1 (de) Epoxysuccinamidsäurederivat
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
ATE146472T1 (de) Umwandlungsverfahren von lorabef dihydrate in loracarbef monohydrate
ATE71364T1 (de) Fluor enthaltende vitamin-d2-derivate.
DK656889A (da) Azabicykliske derivater